🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
45 Servings
Botanical Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 60mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 660mg

Other Ingredients

Vegetable capsule

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Suggested Use: Adults, take two (2) to four (4) capsules daily with food or as directed by a health care practitioner.

🧪 Formulation Notes

Doctor-Formulated European

24% Ginkgoflavonoglycosides 6% Terpene Lactones

Clinical potency Made in the U.S.A.

No magnesium stearate Gluten-free

Vegan formula

Additional Information

The Additive-Free Company

Product Details

DSLD Entry Date 2020-12-26
Product Type Botanical
Form Capsule
Brand Emerald
DSLD ID 239638
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →